326 related articles for article (PubMed ID: 24932597)
21. Circulating insulin-like growth factor 1 levels are reduced in very young children with Prader-Willi syndrome independent of anthropometric parameters and nutritional status.
Koizumi M; Konishi A; Etani Y; Ida S; Kawai M
Clin Endocrinol (Oxf); 2022 Mar; 96(3):346-352. PubMed ID: 34750859
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of growth hormone (GH) deficiency in previously GH-treated young adults with Prader-Willi syndrome.
Donze SH; Damen L; van Alfen-van der Velden JAEM; Bocca G; Finken MJJ; Hoorweg-Nijman GJG; Jira PE; van Leeuwen M; Hokken-Koelega ACS
Clin Endocrinol (Oxf); 2019 Jul; 91(1):118-123. PubMed ID: 30973645
[TBL] [Abstract][Full Text] [Related]
23. IGF-1 Levels, Complex Formation, and IGF Bioactivity in Growth Hormone-Treated Children With Prader-Willi Syndrome.
Bakker NE; van Doorn J; Renes JS; Donker GH; Hokken-Koelega AC
J Clin Endocrinol Metab; 2015 Aug; 100(8):3041-9. PubMed ID: 26050733
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably.
Lindgren AC; Hagenäs L; Müller J; Blichfeldt S; Rosenborg M; Brismar T; Ritzén EM
Acta Paediatr; 1998 Jan; 87(1):28-31. PubMed ID: 9510443
[TBL] [Abstract][Full Text] [Related]
25. Stimulated GH levels during the transition phase in Prader-Willi syndrome.
Grugni G; Marzullo P; Delvecchio M; Iughetti L; Licenziati MR; Osimani S; Ragusa L; Salvatoni A; Sartorio A; Stagi S; Crinò A;
J Endocrinol Invest; 2021 Jul; 44(7):1465-1474. PubMed ID: 33095904
[TBL] [Abstract][Full Text] [Related]
26. The growth hormone-insulin-like growth factor axis in adult patients with Prader Willi syndrome.
Höybye C; Frystyk J; Thorén M
Growth Horm IGF Res; 2003 Oct; 13(5):269-74. PubMed ID: 12932748
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study.
Carrel AL; Myers SE; Whitman BY; Allen DB
J Pediatr; 1999 Feb; 134(2):215-21. PubMed ID: 9931532
[TBL] [Abstract][Full Text] [Related]
28. Sleep-Disordered Breathing in Children with Prader-Willi Syndrome in Relation to Growth Hormone Therapy Onset.
Zimmermann M; Laemmer C; Woelfle J; Fimmers R; Gohlke B
Horm Res Paediatr; 2020; 93(2):85-93. PubMed ID: 32535587
[TBL] [Abstract][Full Text] [Related]
29. Growth hormone improves body composition and motor development in infants with Prader-Willi syndrome after six months.
Whitman B; Carrel A; Bekx T; Weber C; Allen D; Myers S
J Pediatr Endocrinol Metab; 2004 Apr; 17(4):591-600. PubMed ID: 15198290
[TBL] [Abstract][Full Text] [Related]
30. [Changes in carbohydrate metabolism and insulin resistance in patients with Prader-Willi Syndrome (PWS) under growth hormone therapy].
Lämmer C; Weimann E
Wien Med Wochenschr; 2007 Feb; 157(3-4):82-8. PubMed ID: 17340066
[TBL] [Abstract][Full Text] [Related]
31. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
Myers SE; Carrel AL; Whitman BY; Allen DB
J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
[TBL] [Abstract][Full Text] [Related]
32. Growth failure in Prader-Willi syndrome is secondary to growth hormone deficiency.
Thacker MJ; Hainline B; St Dennis-Feezle L; Johnson NB; Pescovitz OH
Horm Res; 1998; 49(5):216-20. PubMed ID: 9568805
[TBL] [Abstract][Full Text] [Related]
33. Hormonal, metabolic and skeletal phenotype of Schaaf-Yang syndrome: a comparison to Prader-Willi syndrome.
McCarthy JM; McCann-Crosby BM; Rech ME; Yin J; Chen CA; Ali MA; Nguyen HN; Miller JL; Schaaf CP
J Med Genet; 2018 May; 55(5):307-315. PubMed ID: 29496979
[TBL] [Abstract][Full Text] [Related]
34. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone therapy improves exercise capacity in adult patients with Prader-Willi syndrome.
Gondoni LA; Vismara L; Marzullo P; Vettor R; Liuzzi A; Grugni G
J Endocrinol Invest; 2008 Sep; 31(9):765-72. PubMed ID: 18997487
[TBL] [Abstract][Full Text] [Related]
36. Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH.
Burman P; Ritzén EM; Lindgren AC
Endocr Rev; 2001 Dec; 22(6):787-99. PubMed ID: 11739333
[TBL] [Abstract][Full Text] [Related]
37. Growth hormone therapy and respiratory disorders: long-term follow-up in PWS children.
Berini J; Spica Russotto V; Castelnuovo P; Di Candia S; Gargantini L; Grugni G; Iughetti L; Nespoli L; Nosetti L; Padoan G; Pilotta A; Trifirò G; Chiumello G; Salvatoni A;
J Clin Endocrinol Metab; 2013 Sep; 98(9):E1516-23. PubMed ID: 23894156
[TBL] [Abstract][Full Text] [Related]
38. Dietary Energy Intake, Body Composition and Resting Energy Expenditure in Prepubertal Children with Prader-Willi Syndrome before and during Growth Hormone Treatment: A Randomized Controlled Trial.
Bakker NE; Siemensma EP; Koopman C; Hokken-Koelega AC
Horm Res Paediatr; 2015; 83(5):321-31. PubMed ID: 25764996
[TBL] [Abstract][Full Text] [Related]
39. Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment.
Nagai T; Obata K; Tonoki H; Temma S; Murakami N; Katada Y; Yoshino A; Sakazume S; Takahashi E; Sakuta R; Niikawa N
Am J Med Genet A; 2005 Jul; 136(1):45-8. PubMed ID: 15937939
[TBL] [Abstract][Full Text] [Related]
40. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study.
Carrel AL; Myers SE; Whitman BY; Allen DB
J Clin Endocrinol Metab; 2002 Apr; 87(4):1581-5. PubMed ID: 11932286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
